ES2120958T3 - Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion. - Google Patents

Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion.

Info

Publication number
ES2120958T3
ES2120958T3 ES91901400T ES91901400T ES2120958T3 ES 2120958 T3 ES2120958 T3 ES 2120958T3 ES 91901400 T ES91901400 T ES 91901400T ES 91901400 T ES91901400 T ES 91901400T ES 2120958 T3 ES2120958 T3 ES 2120958T3
Authority
ES
Spain
Prior art keywords
mutants
oncostatin
activity
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901400T
Other languages
English (en)
Inventor
Peter S Linsley
Jeffrey C Kallestad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2120958T3 publication Critical patent/ES2120958T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDA A FORMAS BIOLOGICAMENTE MUTANTES DEL FACTOR REGULADOR DEL CRECIMIENTO CELULAR ONCOSTATINA M. LOS MUTANTES DE LA ONCOSTATINA M DE LA INVENCION COMPRENDEN MUTANTES DE SUPRESION, SUSTITUCION E INSERCION Y SE PUEDEN PREPARAR UTILIZANDO ADN RECOMBINANTE, IN VITRO, TECNICAS DE EXPRESION DE MUTAGENESIS Y HETEROLOGAS. LOS MUTANTES DE LA ONCOSTATINA M PUEDEN SER UTILES PARA OBTENER RESPUESTAS BIOLOGICAS A LA ONCOSTATINA M Y, COMO TAL, SE PUEDE ENCONTRAR UNA DIVERSIDAD DE USOS TERAPEUTICOS QUE INCLUYEN EL TRATAMIENTO DE LAS NEOPLASIAS, PERO NO ESTAN LIMITADOS AL MISMO.
ES91901400T 1989-12-08 1990-12-07 Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion. Expired - Lifetime ES2120958T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44775989A 1989-12-08 1989-12-08
US62386790A 1990-12-03 1990-12-03

Publications (1)

Publication Number Publication Date
ES2120958T3 true ES2120958T3 (es) 1998-11-16

Family

ID=27035080

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901400T Expired - Lifetime ES2120958T3 (es) 1989-12-08 1990-12-07 Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion.

Country Status (17)

Country Link
EP (1) EP0504291B1 (es)
JP (1) JPH05504134A (es)
KR (1) KR920703636A (es)
CN (1) CN1055389A (es)
AT (1) ATE168117T1 (es)
AU (1) AU651330B2 (es)
CA (1) CA2070171A1 (es)
DE (1) DE69032471T2 (es)
DK (1) DK0504291T3 (es)
ES (1) ES2120958T3 (es)
FI (1) FI104424B (es)
GR (1) GR3027654T3 (es)
IL (1) IL96593A0 (es)
NO (1) NO301769B1 (es)
NZ (1) NZ236382A (es)
PT (1) PT96134B (es)
WO (1) WO1991009057A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
CA2178256A1 (en) * 1995-06-06 1996-12-07 Christopher H. Clegg Oncostatin m induced hematopoiesis
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases

Also Published As

Publication number Publication date
EP0504291B1 (en) 1998-07-08
AU651330B2 (en) 1994-07-21
NO922202L (no) 1992-06-04
FI104424B (fi) 2000-01-31
KR920703636A (ko) 1992-12-18
NO922202D0 (no) 1992-06-04
PT96134B (pt) 1998-04-30
DK0504291T3 (da) 1998-11-30
EP0504291A1 (en) 1992-09-23
AU7036191A (en) 1991-07-18
IL96593A0 (en) 1991-09-16
CN1055389A (zh) 1991-10-16
WO1991009057A1 (en) 1991-06-27
DE69032471T2 (de) 1999-03-04
ATE168117T1 (de) 1998-07-15
NZ236382A (en) 1992-08-26
CA2070171A1 (en) 1991-06-09
FI922612L (fi) 1992-06-05
JPH05504134A (ja) 1993-07-01
GR3027654T3 (en) 1998-11-30
EP0504291A4 (en) 1992-10-28
FI922612A0 (fi) 1992-06-05
PT96134A (pt) 1991-09-30
DE69032471D1 (de) 1998-08-13
NO301769B1 (no) 1997-12-08

Similar Documents

Publication Publication Date Title
ES9000011A1 (es) Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
ES2147720T3 (es) Factor de celulas madre.
DE3771747D1 (de) Stimulation des haarwachstums.
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
ES2055684T3 (es) Un metodo para preparar un agente para el tratamiento de la leucopenia.
AR036827A1 (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas
ES2073574T3 (es) Introduccion de liposomas en el tejido isquemico.
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
AR246983A1 (es) Plasmido dna recombinante, linea celular y procedimiento para producir beta-ngf humano.
ES2131513T3 (es) Utilizacion de interferon-beta 2a humano para la preparacion de medicamentos.
ES2001003A4 (es) Metodo para preparar polimeros de sulfometil-poliacrilamidas.
ES2039624T3 (es) Vectores de expresion para la produccion del factor estimulante de colonias de granulocitos macrofagos de seres humanos en una celula hospedante de mamifero.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
ITRM970238A0 (it) Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali
ES2150902T3 (es) Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos.
ES2064082T3 (es) Proteinas bcrf1 como inhibidores de interferon-gamma.
ES2074560T3 (es) Procedimiento para la produccion de un animal transgenico no humano mediante la introduccion de adn exogeno en celulas animales somaticas y germinales.
ATE225183T1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
DE68924222D1 (de) Megakaryocytopoietin, seine Herstellung und Benutzung.
CO4410254A1 (es) Procedimiento para introducir material extrano en celulas eucarioticas superiores
ES2052625T3 (es) Procedimiento para la obtencion de componentes de pared celular a partir de arcaebacterias y su empleo como medicamentos.
ES2074599T3 (es) Procedimiento para preparar ciclobutanos sustituidos.
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
GR3027654T3 (en) Novel proteins with oncostatin m activity and process for their preparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 504291

Country of ref document: ES